Holen Sie sich die Stockscreener-App
0.7196
1.95%
-0.0143
Handel nachbörslich:
.72
0.0004
+0.06%
Schlusskurs vom Vortag:
$0.7339
Offen:
$0.7339
24-Stunden-Volumen:
1.26M
Relative Volume:
1.09
Marktkapitalisierung:
$76.76M
Einnahmen:
$45.44M
Nettoeinkommen (Verlust:
$-35.43M
KGV:
-2.1165
EPS:
-0.34
Netto-Cashflow:
$-25.39M
1W Leistung:
-10.94%
1M Leistung:
-45.07%
6M Leistung:
-47.86%
1J Leistung:
-82.32%
1-Tages-Spanne:
$0.696
$0.7429
1-Wochen-Bereich:
$0.6806
$0.8431
52-Wochen-Spanne:
$0.6806
$4.32
Maxcyte Inc Stock (MXCT) Company Profile
Firmenname
Maxcyte Inc
Sektor
Branche
Telefon
301-517-5556
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
0.7196 | 78.29M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | Eingeleitet | Stephens | Overweight |
| 2023-11-29 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | BTIG Research | Buy |
| 2021-08-24 | Eingeleitet | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | Stephens | Overweight |
| 2021-08-24 | Eingeleitet | Stifel | Buy |
| 2021-08-24 | Eingeleitet | Wedbush | Outperform |
| 2021-08-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January - MarketBeat
Is MaxCyte Inc. being accumulated by smart money2025 Institutional Moves & Daily Market Momentum Tracking - mfd.ru
Will MaxCyte Inc. stock outperform Nasdaq indexJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru
Is MaxCyte Inc. stock gaining market shareTreasury Yields & Short-Term High Return Ideas - mfd.ru
Capricorn Fund Managers Ltd Acquires 8,200,000 Shares in MaxCyte Inc - GuruFocus
What are MaxCyte Inc.’s recent SEC filings showingWeekly Loss Report & Weekly High Return Opportunities - mfd.ru
Is MaxCyte Inc. stock a value trapJuly 2025 Review & Real-Time Stock Movement Alerts - mfd.ru
Will MaxCyte Inc. benefit from rising consumer demandBond Market & Community Trade Idea Sharing - mfd.ru
Brokerages Set MaxCyte, Inc. (NASDAQ:MXCT) PT at $7.00 - Defense World
MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen - MarketBeat
MaxCyte (NASDAQ:MXCT) Stock Price Down 4.2%Here's Why - MarketBeat
Sentiment Recap: Can ATGL grow without dilutionQuarterly Growth Report & Technical Entry and Exit Tips - baoquankhu1.vn
MaxCyte team building boosts morale at sales meeting - Traders Union
Hedge Fund Moves: Will MaxCyte Inc outperform small cap indexes2025 Earnings Surprises & Reliable Intraday Trade Plans - baoquankhu1.vn
Aug Action: Is MaxCyte Inc showing insider buyingDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
IPO Launch: Is MaxCyte Inc showing insider buying2025 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Can MaxCyte Inc. disrupt its industryWeekly Loss Report & Daily Profit Maximizing Tips - mfd.ru
Hedge Fund Bets: Is Algoma Steel Group Inc benefiting from interest rate changesMarket Performance Recap & High Return Stock Watch Alerts - baoquankhu1.vn
Rally Mode: Is MaxCyte Inc showing insider buyingTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
Dip Buying: Is INEO forming a breakout patternJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Death Cross: What is the next catalyst for MaxCyte IncGap Up & Low Drawdown Investment Ideas - baoquankhu1.vn
Investor Mood: How interest rate cuts could boost MaxCyte Inc stockQuarterly Profit Report & Community Verified Trade Signals - Bộ Nội Vụ
MaxCyte to join the 2026 G-Rex Grant Tour in Houston - Traders Union
Published on: 2026-01-14 11:01:42 - baoquankhu1.vn
Day Trade: Is MaxCyte Inc stock affected by interest rate hikesOil Prices & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
MaxCyte announces preliminary unaudited fourth quarter and full year 2025 financial results - marketscreener.com
Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results - TradingView — Track All Markets
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - Benzinga
MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Risk Off: Can TriNet Group Inc. stock maintain growth trajectory2025 Technical Patterns & Fast Entry Momentum Trade Alerts - moha.gov.vn
Will MaxCyte Inc. stock rally after Fed decisionsStop Loss & Weekly Market Pulse Alerts - Улправда
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - MarketBeat
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments - MSN
MaxCyte: Building the Future of Cell and Gene Therapy Innovation - MSN
How strong is MaxCyte Inc. stock balance sheet2025 Performance Recap & Community Driven Trade Alerts - Улправда
Is MaxCyte Inc. stock attractive after correctionTrail vs Road Selection & walk-ready comfort choices - ulpravda.ru
Will MaxCyte Inc. stock gain from government policiesTrade Volume Report & Entry and Exit Point Strategies - Улправда
Why MaxCyte Inc. stock remains undervaluedJuly 2025 Trends & Verified Short-Term Trading Plans - Улправда
Aug Outlook: Will MaxCyte Inc. stock gain from government policiesWeekly Trade Report & Risk Managed Investment Entry Signals - Улправда
How sustainable is MaxCyte Inc. stock dividend payout2025 Technical Patterns & Weekly Breakout Stock Alerts - Улправда
Will MaxCyte Inc. stock outperform value stocksWeekly Gains Report & Free Community Supported Trade Ideas - ulpravda.ru
Downgrade Watch: Why retail investors pile into MaxCyte Inc. stockQuarterly Profit Report & Accurate Buy Signal Notifications - ulpravda.ru
MaxCyte (NASDAQ:MXCT) Shares Up 0.7%Time to Buy? - MarketBeat
MaxCyte (NASDAQ:MXCT) Shares Up 0.7% – Time to Buy? - Defense World
Bear Alert: How strong is MaxCyte Inc stock balance sheet2025 Market Sentiment & Real-Time Volume Analysis - moha.gov.vn
Aug Patterns: Will MaxCyte Inc stock gain from government policiesInflation Watch & Safe Capital Growth Stock Tips - moha.gov.vn
MaxCyte, Inc.Common Stock (NQ: MXCT - FinancialContent
Will MaxCyte Inc. stock attract more institutional investorsBlue Chip Stock Analysis & Free Trading Psychology Coaching - Улправда
Will MaxCyte Inc. stock deliver strong dividend growth2026 world cup usa national team group stage defensive leaders pressing system tactical prediction guide - Улправда
MaxCyte eyes growth in cell engineering for 2026 - Traders Union
Finanzdaten der Maxcyte Inc-Aktie (MXCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Maxcyte Inc-Aktie (MXCT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
161,811 |
| Masoud Maher | President and CEO |
Aug 13 '25 |
Buy |
1.37 |
75,000 |
102,915 |
175,000 |
| Erck Stanley C | Director |
Aug 13 '25 |
Buy |
1.37 |
100,000 |
137,220 |
398,328 |
| DOUGLAS RICHARD | Director |
Aug 13 '25 |
Buy |
1.39 |
80,000 |
111,040 |
230,577 |
| Brooke William W | Director |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
150,879 |
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):